|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,844.50 GBX | +0.08% |
|
-2.97% | +1.10% |
| 05-11 | Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool… |  |
| 05-11 | GSK plc and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Enter Exclusive Collaboration for Bepirovirsen in China | CI |
| Capitalization | 73.63B 100B 85.27B 78.09B 137B 9,574B 138B 926B 361B 4,560B 377B 369B 15,779B | P/E ratio 2026 * |
11.6x | P/E ratio 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise value | 86.01B 117B 99.61B 91.23B 160B 11,184B 162B 1,082B 422B 5,326B 440B 431B 18,432B | EV / Sales 2026 * |
2.55x | EV / Sales 2027 * | 2.35x |
| Free-Float |
92.31% | Yield 2026 * |
3.79% | Yield 2027 * | 3.97% |
Last Transcript: GSK plc
| 1 day | +0.08% | ||
| 1 week | -2.97% | ||
| Current month | -4.36% | ||
| 1 month | -15.23% | ||
| 3 months | -14.92% | ||
| 6 months | +4.09% | ||
| Current year | +1.10% |
| 1 week | 1,831.5 |  | 1,896.5 |
| 1 month | 1,831.5 | | 2,202 |
| Current year | 1,774 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
| Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 68 | 2019-08-31 |
Charles Bancroft
BRD | Director/Board Member | 66 | 2020-04-30 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.40% | 3.15% | 27 M€ | |
| +13.09% | 2.51% | 12 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -2.97% | +33.90% | +28.41% | 100B | |
| +1.95% | -0.10% | +31.64% | +122.02% | 846B | |
| +0.05% | -1.24% | +43.58% | +37.54% | 533B | |
| +0.61% | -2.58% | +9.85% | +38.33% | 356B | |
| -0.94% | -0.97% | +22.40% | +12.53% | 324B | |
| +1.18% | -0.07% | +31.86% | +14.23% | 282B | |
| +0.30% | -1.90% | +25.07% | +23.67% | 278B | |
| -0.09% | -1.62% | +46.48% | -5.33% | 275B | |
| +3.34% | +7.91% | -32.48% | -47.44% | 203B | |
| -0.64% | +1.77% | +23.97% | +41.89% | 179B | |
| Average | +0.58% | -0.91% | +23.63% | +26.58% | 337.56B | |
| Weighted average by Cap. | +0.76% | -1.22% | +26.84% | +44.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.77B 46.09B 39.11B 35.82B 62.99B 4,391B 63.5B 425B 166B 2,091B 173B 169B 7,237B | 35.39B 48.3B 40.98B 37.53B 66.01B 4,601B 66.54B 445B 174B 2,191B 181B 177B 7,584B |
| Net income | 6.35B 8.67B 7.36B 6.74B 11.85B 826B 11.95B 79.91B 31.19B 393B 32.53B 31.85B 1,361B | 6.72B 9.17B 7.78B 7.13B 12.53B 874B 12.63B 84.5B 32.98B 416B 34.4B 33.68B 1,440B |
| Net Debt | 12.38B 16.9B 14.34B 13.13B 23.1B 1,610B 23.28B 156B 60.79B 767B 63.41B 62.08B 2,654B | 9.49B 12.95B 10.99B 10.06B 17.7B 1,234B 17.84B 119B 46.58B 588B 48.58B 47.56B 2,033B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-11 | 1,844.50 p | +0.08% | 9,314,552 |
| 26-05-08 | 1,843.00 p | -0.83% | 6,109,465 |
| 26-05-07 | 1,858.50 p | -0.88% | 14,943,290 |
| 26-05-06 | 1,875.00 p | +0.97% | 8,582,557 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition